惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园 - 司徒正美
月光博客
月光博客
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
美团技术团队
WordPress大学
WordPress大学
罗磊的独立博客
Last Week in AI
Last Week in AI
人人都是产品经理
人人都是产品经理
爱范儿
爱范儿
MongoDB | Blog
MongoDB | Blog
J
Java Code Geeks
H
Hackread – Cybersecurity News, Data Breaches, AI and More
H
Help Net Security
S
SegmentFault 最新的问题
C
Check Point Blog
酷 壳 – CoolShell
酷 壳 – CoolShell
腾讯CDC
Engineering at Meta
Engineering at Meta
The GitHub Blog
The GitHub Blog
F
Fortinet All Blogs
D
DataBreaches.Net
雷峰网
雷峰网
GbyAI
GbyAI
宝玉的分享
宝玉的分享

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Unilever PLC (UL) Q1 2026 Sales/Trading Call Transcript
SA Transcripts · 2026-05-02 · via All Articles on Seeking Alpha

Unilever PLC (UL) Q1 2026 Sales/Trading Call April 30, 2026 3:00 AM EDT

Company Participants

Fernando Fernandez - CEO & Director
Srinivas Phatak - CFO & Director
Jemma Spalton - Head of Investor Relations

Conference Call Participants

Warren Ackerman - Barclays Bank PLC, Research Division
Celine Pannuti - JPMorgan Chase & Co, Research Division
Nicolas Jerome Ceron - BofA Securities, Research Division
Jeff Stent - BNP Paribas, Research Division
James Jones - RBC Capital Markets, Research Division
Jean-Olivier Nicolai - Goldman Sachs Group, Inc., Research Division
Callum Elliott - Bernstein Institutional Services LLC, Research Division
Karel Zoete - Kepler Cheuvreux, Research Division
David Hayes - Jefferies LLC, Research Division
Jeremy Fialko - HSBC Global Investment Research
Sarah Simon - Morgan Stanley, Research Division
Tom Sykes - Deutsche Bank AG, Research Division
Guillaume Gerard Delmas - UBS Investment Bank, Research Division
Edward Lewis - Rothschild & Co Redburn, Research Division

Presentation

Fernando Fernandez
CEO & Director

Good morning and thank you for joining us for Unilever's first quarter trading statement for 2026. I am joined today by Srini Phatak, our Chief Financial Officer. In a moment, Srini will take you through the detail of the quarter. I will also come back to say a few words on the recent announcement regarding our Foods business, and why we believe this is the right move for Foods, for Unilever, and ultimately for our shareholders that will unlock significant value.

But first, let me set out what I see as the key elements of our performance in the first quarter. We made a good start to the year. Growth was solid, and importantly in line with the strategic priorities we have set for the business.

We delivered underlying sales growth of 3.8% driven by a strong volume growth of 2.9% in the quarter. Growth was broad-based across categories, with a particularly strong quarter in Home Care with volumes up 6.2% driven by a